Rheumatologic and Autoimmune Diseases
Systemic Lupus Erythematosus (SLE)
In severe or therapy-resistant cases of lupus, immunoadsorption can be used to remove anti-DNA antibodies and immune complexes, particularly when the kidneys or central nervous system (CNS) are affected.
This targeted therapy helps reduce inflammation and immune overactivity.
Rheumatoid Arthritis
In treatment-resistant forms of rheumatoid arthritis, immunoadsorption is applied to lower rheumatoid factors and inflammatory proteins in the blood.
This can help reduce disease activity, alleviate joint inflammation, and improve quality of life.
Systemic Sclerosis (Scleroderma)
In systemic sclerosis, double-filtration plasmapheresis (DFPP) has shown promising results in experimental and clinical studies.
The procedure can reduce fibrosis-related immune complexes and circulating cytokines, helping to improve vascular function and microcirculation.